Want to join the conversation?
$SRCL 2Q15 Q&A: Ryan of William Blair asks on initiative on cross-selling or any new product launches that might skew LQ growth upwards a little bit? Charles, CEO: No change to the guidance. All the growth engines performed well. Headwind on fuel surcharges will bring down the growth rates roughly about 1% of all the LQ and SQ.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?